Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1

Background and Aims: Tongxinluo (TXL) is a multifunctional traditional Chinese medicine that has been widely used to treat cardiovascular and cerebrovascular diseases. However, no studies have explored whether TXL can protect human cardiomyocytes (HCMs) from ischemia/reperfusion (I/R) injury. Reperf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Chen, Gui-hao, Xu, Chuan-sheng, Zhang, Jie, Li, Qing, Cui, He-he, Li, Xiang-dong, Chang, Li-ping, Tang, Rui-jie, Xu, Jun-yan, Tian, Xia-qiu, Huang, Pei-sen, Xu, Jun, Jin, Chen, Yang, Yue-jin
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2017
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5670141/
https://ncbi.nlm.nih.gov/pubmed/29163161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2017.00775
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars